SYNERGIA MEDICAL ANNOUNCES STRONG RESULTS FOR NAO.VNS FIRST-IN-HUMAN STUDY
Primary safety endpoint met - No serious adverse events reported over 3-monthsRobust…
Tag: synergia
Primary safety endpoint met - No serious adverse events reported over 3-monthsRobust…
